Hypoxia-inducible factor-1α (HIF-1α), a key modulator under hypoxia conditions, has been clinically revealed that its positive expression is significantly correlated with GC progression and development, and it can be a potent inducer in GC (8, 9). This evidence concerns the gene HIF1A and gastric cancer.